News & Updates

Show Multimedia Only
Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

15 Jul 2023

Time to recovery from COVID-19 pneumonia does not appear to differ following treatment with abatacept, cenicriviroc, or infliximab among hospitalized patients, according to a study.

15 Jul 2023
Danuglipron helps with glucose control, weight loss in T2D

Danuglipron helps with glucose control, weight loss in T2D

15 Jul 2023 byJairia Dela Cruz

The glucagon-like peptide 1 receptor (GLP-1R) agonist danuglipron appears to be beneficial in the treatment of patients with type 2 diabetes (T2D), yielding reductions in glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), and body weight, without fasting restrictions, as shown in the results of a phase IIb study.

15 Jul 2023
Long-acting ART induces viral suppression in people with HIV Long-acting ART induces viral suppression in people with HIV

Long-acting ART induces viral suppression in people with HIV

15 Jul 2023

People with HIV (PWH) who are treated with long-acting (LA) antiretroviral therapy (ART) achieve virologic suppression, as do those with viraemia and challenges to adherence, reports a study.

15 Jul 2023
Anxiety, depression jeopardize health of axSpA patients

Anxiety, depression jeopardize health of axSpA patients

14 Jul 2023 byJairia Dela Cruz

Patients with axial spondyloarthritis (axSpA) may experience a decline in their overall health and functioning due to the presence of comorbid anxiety and depression, as reported in a study from Singapore.

14 Jul 2023
Ustekinumab shows efficacy in Asians with plaque psoriasis

Ustekinumab shows efficacy in Asians with plaque psoriasis

14 Jul 2023 byStephen Padilla

Asian patients with moderate to severe plaque psoriasis may benefit from ustekinumab therapy, which has been shown to be both safe and effective in a Singapore study.

14 Jul 2023